Merck & Co. and Schering-Plough Corp. suspended television ads Tuesday for the cholesterol pills Vytorin and Zetia after a study questioned the benefit of the medicines. The Vytorin commercials were ...

The makers of the cholesterol drug Vytorin pulled its telelvision ads off the air on Tuesday, after a study found the drug was no more effective at reducing the risk of heart attack than one of its ...

A new Mayo Clinicstudy found that Vytorin, made by Merck/Schering-Plough Pharmaceuticals, worked better that Lipitor, a Pfizerproduct, to reduce bad cholesterol in patients with diabetes and high ...

NEW YORK, Jan 3 (Reuters) - The chief executive of Merck & Co on Thursday said the company's Vytorin cholesterol fighter will likely get a future sales boost as patients fail to adequately benefit ...

WHITEHOUSE STATION -- Merck & Co. and its Schering unit sued Teva Pharmaceutical Industries Ltd. to prevent it from selling a generic version of the cholesterol drug Vytorin in the U.S. until 2017.